Executive Overview

SEMAX is a high-potency synthetic neuropeptide originally developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. It is a precision-engineered analogue of the ACTH (4-10) fragment, specifically the heptapeptide sequence Met-Glu-His-Phe-Pro-Gly-Pro.

By appending a Pro-Gly-Pro tripeptide to the C-terminus, the molecule achieves exceptional metabolic stability and prolonged biological activity within the central nervous system (CNS), while remaining entirely devoid of the systemic hormonal activity associated with full-length adrenocorticotropic hormone.

Multifaceted Mechanism of Action

SEMAX is researched for its ability to cross the blood-brain barrier and exert direct regulatory effects on neuronal tissue through several distinct pathways:

1. Neurotrophic Factor Upregulation

SEMAX is noted for its ability to rapidly stimulate the synthesis of key neurotrophins:

• Brain-Derived Neurotrophic Factor (BDNF): Enhances synaptic plasticity and the formation of long-term memory.

• Nerve Growth Factor (NGF): Supports the survival and maintenance of cholinergic and sensory neurons.

2. Neuroprotection & Hypoxia Resilience

The peptide exhibits strong neuroprotective properties, particularly during oxidative stress or ischemic events. It modulates the expression of genes involved in the inflammatory response and promotes survival pathways in neurons deprived of oxygen (hypoxia).

3. Neurotransmitter Modulation

SEMAX influences the dopaminergic and serotonergic systems. By regulating the levels of these monoamines, it is studied for its capacity to improve executive function, heighten focus, and stabilize mood under conditions of mental fatigue or environmental stress.

Technical Specifications

Research Applications

In laboratory and clinical research settings, SEMAX is investigated for its potential efficacy in:

• Cerebrovascular Recovery: Analyzing its role in post-stroke rehabilitation and transient ischemic attack (TIA) recovery.

• Cognitive Optimization: Studying memory consolidation, attention span, and cognitive performance in healthy and impaired models.

• Optic Nerve Health: Investigating neuroprotective effects in cases of optic nerve disease and glaucoma.

• Resilience Modeling: Monitoring neuro-metabolic stability during periods of acute sleep deprivation or high-intensity cognitive load.

Handling & Storage Protocols

To ensure the biological activity of the heptapeptide:

• Stability: The lyophilized powder is highly stable but should be stored at -20°C for long-term archiving.

• Reconstitution: Once dissolved in a research-grade diluent (e.g., Bacteriostatic Water), the solution must be stored at 2°C to 8°C.

• Integrity: Avoid exposure to direct UV light and excessive mechanical stress.

Strict Laboratory Disclaimer

FOR RESEARCH USE ONLY: This compound is synthesized and intended exclusively for in vitro laboratory analysis and scientific research. It is not intended for human or veterinary consumption, medical diagnosis, or therapeutic use. All information provided is for educational purposes and does not constitute medical advice.